VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 160 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 12.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $94,747 | -58.6% | 12,821 | -44.6% | 0.00% | -66.7% |
| Q3 2022 | $229,000 | -72.4% | 23,155 | -69.6% | 0.00% | -66.7% |
| Q2 2022 | $829,000 | -69.4% | 76,063 | -68.3% | 0.01% | -60.9% |
| Q1 2022 | $2,710,000 | +43.6% | 239,627 | +99.2% | 0.02% | +64.3% |
| Q4 2021 | $1,887,000 | -12.2% | 120,298 | -4.1% | 0.01% | -12.5% |
| Q3 2021 | $2,150,000 | -25.1% | 125,417 | -6.0% | 0.02% | -20.0% |
| Q2 2021 | $2,870,000 | +39.7% | 133,411 | -2.4% | 0.02% | +42.9% |
| Q1 2021 | $2,054,000 | +17.2% | 136,758 | +2.5% | 0.01% | 0.0% |
| Q4 2020 | $1,753,000 | +160.9% | 133,389 | +91.8% | 0.01% | +100.0% |
| Q3 2020 | $672,000 | +71.9% | 69,548 | +103.3% | 0.01% | +75.0% |
| Q2 2020 | $391,000 | +33.4% | 34,206 | +20.9% | 0.00% | 0.0% |
| Q1 2020 | $293,000 | -35.0% | 28,287 | +2.9% | 0.00% | 0.0% |
| Q4 2019 | $451,000 | +137.4% | 27,479 | +92.3% | 0.00% | +100.0% |
| Q3 2019 | $190,000 | – | 14,286 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |